3.74

1.91% 0.07

After Hours: 3.76 0.02 +0.53%

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $3.74, with a volume of 3.30M. It is up +1.91% in the last 24 hours and down -13.63% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Previous Close:

$3.67

Open:

$3.645

24h Volume:

3.30M

Relative Volume:

0.57

Market Cap:

$1.32B

Revenue:

$6.23M

Net Income/Loss:

$-95.90M

P/E Ratio:

-9.5897

EPS:

-0.39

Net Cash Flow:

$-68.47M

1W Performance:

-11.37%

1M Performance:

-13.63%

6M Performance:

+172.99%

1Y Performance:

+334.93%

1-Day Range:

$3.54

$3.7851

1-Week Range:

$3.54

$4.485

52-Week Range:

$0.6513

$5.225

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1136)

Industry

Biotechnology (634)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2025-03-19

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	3.74	1.30B	6.23M	-95.90M	-68.47M	-0.39
VRTX Vertex Pharmaceuticals Inc	432.17	109.05B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	784.61	82.75B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	445.12	56.78B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.63	56.52B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.51	44.58B	447.02M	-1.18B	-906.14M	-6.1812

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

Nov 26, 2025

Can Precigen's (PGEN) Revenue Surge Offset Concerns About Its Expanding Losses? - simplywall.st

Nov 26, 2025

Nov 25, 2025

Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN) - Seeking Alpha

Nov 25, 2025

Nov 24, 2025

Precigen Insider Sold Shares Worth $12,291,748, According to a Recent SEC Filing - MarketScreener

Nov 24, 2025

Nov 23, 2025

Precigen (PGEN) director Kirk sells shares worth $12.3 million By Investing.com - Investing.com Australia

Nov 22, 2025

Nov 21, 2025

Precigen (PGEN) director Kirk sells shares worth $12.3 million - Investing.com

Nov 21, 2025

[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan

Nov 21, 2025

Precigen, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo

Nov 21, 2025

Precigen Stock Opens Weak with 11.75% Gap Down Amid Market Concerns - Markets Mojo

Nov 21, 2025

Nov 20, 2025

Shareholder Kapital Joe LLC Files To Sell 942,832 Of Precigen Inc [PGEN] - TradingView

Nov 20, 2025

Is Precigen Inc. stock supported by strong cash flowsJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com

Nov 20, 2025

Can technical indicators confirm Precigen Inc.’s reversal2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

How to integrate Precigen Inc. into portfolio analysis tools - newser.com

Nov 19, 2025

Earnings visualization tools for Precigen Inc.2025 Institutional Moves & Short-Term Trading Alerts - newser.com

Nov 19, 2025

Published on: 2025-11-19 18:31:23 - newser.com

Nov 19, 2025

How Precigen Inc. stock performs in interest rate cyclesJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com

Nov 19, 2025

Will Precigen Inc. stock benefit from commodity prices2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com

Nov 19, 2025

Shareholder Kapital Joe LLC Files To Sell 1,086,153 Of Precigen Inc [PGEN] - TradingView

Nov 19, 2025

Precigen (PGEN) Q3 2025 Earnings Call Transcript - AOL.com

Nov 19, 2025

Is Precigen Inc. stock in correction or buying zone2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 19, 2025

Using data tools to time your Precigen Inc. exit2025 Valuation Update & AI Based Buy and Sell Signals - newser.com

Nov 19, 2025

Tools to assess Precigen Inc.’s risk profileQuarterly Market Summary & Daily Price Action Insights - newser.com

Nov 19, 2025

Will Precigen Inc. stock benefit from AI adoptionJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com

Nov 19, 2025

Nov 18, 2025

Using R and stats models for Precigen Inc. forecastingRisk Management & Weekly Top Performers Watchlists - newser.com

Nov 18, 2025

Nov 17, 2025

US High Growth Tech Stocks to Watch in November 2025 - simplywall.st

Nov 17, 2025

Vaxart, Precigen among biotech gainers after Q3 results - MSN

Nov 17, 2025

Is Now The Right Time To Watch Precigen's Commercial Launch Story? - RTTNews

Nov 17, 2025

Intraday pattern recognizer results for Precigen Inc.Quarterly Portfolio Report & Free Community Supported Trade Ideas - newser.com

Nov 17, 2025

Nov 16, 2025